# Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)

Study · id `cardio:ct-nct01456949` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01456949](<https://clinicaltrials.gov/study/NCT01456949>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01456949

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 402 participants.

## Technical summary

Registry record NCT01456949. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06-26 (actual); primary completion 2017-11-30 (actual). Results posted on 2019-01-11.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 402 participants (enrolled count; ClinicalTrials.gov record NCT01456949, source copy `cardio:ctgov-nct01456949-2025-02-13`, retrieved 2026-10-26)
- Started: 2012-06-26 (actual) (ClinicalTrials.gov record NCT01456949, source copy `cardio:ctgov-nct01456949-2025-02-13`, retrieved 2026-10-26)
- Primary completion: 2017-11-30 (actual) (ClinicalTrials.gov record NCT01456949, source copy `cardio:ctgov-nct01456949-2025-02-13`, retrieved 2026-10-26)
- Completion: 2017-11-30 (actual) (ClinicalTrials.gov record NCT01456949, source copy `cardio:ctgov-nct01456949-2025-02-13`, retrieved 2026-10-26)
- Results first posted: 2019-01-11 (ClinicalTrials.gov record NCT01456949, source copy `cardio:ctgov-nct01456949-2025-02-13`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT01456949, source copy `cardio:ctgov-nct01456949-2025-02-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01456949-2025-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
- Acronym: STOP AF PAS
- Condition: Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Device): Medtronic Arctic Front® Cardiac CryoAblation System
- Lead sponsor: Medtronic Cardiac Ablation Solutions
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Ablation Solutions (`cardio:org-medtronic-cardiac-ablation-solutions`)

## Provenance

Content hash: 2c5f84a5171851cd15c8873cbacee1d28b67428b7d1bd377ddab7317a6fb7038
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
